These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 24594263

  • 1. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY, He Q, Xiang-Lian L, Ya-Nan Y, Si-Te F.
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [Abstract] [Full Text] [Related]

  • 2. Macrolide antibiotics for bronchiectasis.
    Kelly C, Chalmers JD, Crossingham I, Relph N, Felix LM, Evans DJ, Milan SJ, Spencer S.
    Cochrane Database Syst Rev; 2018 Mar 15; 3(3):CD012406. PubMed ID: 29543980
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials.
    Fan LC, Lu HW, Wei P, Ji XB, Liang S, Xu JF.
    BMC Infect Dis; 2015 Mar 27; 15():160. PubMed ID: 25888483
    [Abstract] [Full Text] [Related]

  • 6. Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.
    Gao YH, Guan WJ, Xu G, Tang Y, Gao Y, Lin ZY, Lin ZM, Zhong NS, Chen RC.
    PLoS One; 2014 Mar 27; 9(3):e90047. PubMed ID: 24603554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis.
    Lee E, Sol IS, Kim JD, Yang HJ, Min TK, Jang GC, Hwang YH, Cho HJ, Suh DI, Kim K, Kim HS, Kim YH, Woo SI, Lee YJ, Jung S, Jeon YH.
    Sci Rep; 2021 Dec 20; 11(1):24287. PubMed ID: 34930997
    [Abstract] [Full Text] [Related]

  • 10. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P.
    Drugs; 2007 Dec 20; 67(7):965-74. PubMed ID: 17488142
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions.
    Haworth CS, Bilton D, Elborn JS.
    Respir Med; 2014 Oct 20; 108(10):1397-408. PubMed ID: 25301290
    [Abstract] [Full Text] [Related]

  • 14. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB, Bruce KD, Martin ML, Burr LD, Serisier DJ.
    Lancet Respir Med; 2014 Dec 20; 2(12):988-96. PubMed ID: 25458200
    [Abstract] [Full Text] [Related]

  • 15. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides.
    El Boustany P, Gachelin E, Colomban C, Cernoia J, Sudour P, Carsin A, Dubus JC.
    Pediatr Pulmonol; 2019 Apr 20; 54(4):487-496. PubMed ID: 30652424
    [Abstract] [Full Text] [Related]

  • 16. Inhaled antibiotics in non-cystic fibrosis bronchiectasis: A meta-analysis.
    Xu L, Zhang F, Du S, Yu Q, Chen L, Long LH, Li YM, Jia AH.
    Pharmazie; 2016 Sep 01; 71(9):491-498. PubMed ID: 29441843
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
    Serisier DJ, Martin ML, McGuckin MA, Lourie R, Chen AC, Brain B, Biga S, Schlebusch S, Dash P, Bowler SD.
    JAMA; 2013 Mar 27; 309(12):1260-7. PubMed ID: 23532242
    [Abstract] [Full Text] [Related]

  • 20. The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis.
    Aksamit T, Bandel TJ, Criollo M, De Soyza A, Elborn JS, Operschall E, Polverino E, Roth K, Winthrop KL, Wilson R.
    Contemp Clin Trials; 2017 Jul 27; 58():78-85. PubMed ID: 28495619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.